| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/24/2001 | CA2046865C Inosine-guanosine kinase |
| 04/24/2001 | CA2002210C Expression and processing of authentic fgf's in yeast |
| 04/24/2001 | CA1341216C Human .alpha.-1-antitrypsin derivatives, and a production process |
| 04/21/2001 | CA2321266A1 Anti-dnase-gamma antibody, and production and use thereof |
| 04/20/2001 | CA2322555A1 New nucleotide sequences which code for the pck gene |
| 04/19/2001 | WO2001027857A2 Methods for generating databases and databases for identifying polymorphic genetic markers |
| 04/19/2001 | WO2001027632A2 Cellular receptor mutations predicted by multiple-sequence-allignment |
| 04/19/2001 | WO2001027630A2 Methods to identify compounds that modulate neuronal activity |
| 04/19/2001 | WO2001027622A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | WO2001027613A2 Improved method for the detection of acid resistant microorganisms in a stool |
| 04/19/2001 | WO2001027612A2 Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool |
| 04/19/2001 | WO2001027331A2 Detection of nucleic acid heteroduplex molecules by anion-exchange chromatography |
| 04/19/2001 | WO2001027328A1 Particle analysis assay for biomolecular quantification |
| 04/19/2001 | WO2001027326A2 Template-dependent ligation with pna-dna chimeric probes |
| 04/19/2001 | WO2001027324A2 Converting diploidy to haploidy for genetic diagnosis |
| 04/19/2001 | WO2001027320A1 SUSPENSION SYSTEM FOR SEQUENCING GENETIC SUBSTANCE, METHOD OF SEQUENCING GENETIC SUBSTANCE BY USING THE SUSPENSION SYSTEM, AND METHOD OF HIGH-SPEED SNPs SCORING BY USING THE SUSPENSION SYSTEM |
| 04/19/2001 | WO2001027319A2 Leptin assay based on detecting ang-2 expression |
| 04/19/2001 | WO2001027317A2 Method for distinguishing 5-position methylation changes |
| 04/19/2001 | WO2001027316A1 Luminescence test system |
| 04/19/2001 | WO2001027315A2 For substances acting on msk1 or msk2 |
| 04/19/2001 | WO2001027307A1 Method for production of l-cysteine or l-cysteine derivatives by fermentation |
| 04/19/2001 | WO2001027306A2 Biosynthesis of polyketide synthase substrates |
| 04/19/2001 | WO2001027304A2 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 04/19/2001 | WO2001027303A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 04/19/2001 | WO2001027302A1 Recombinant, replication defective celo virus and celo virus dna |
| 04/19/2001 | WO2001027301A2 System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae |
| 04/19/2001 | WO2001027300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/19/2001 | WO2001027299A1 Vectors and methods for recombinant protein expression |
| 04/19/2001 | WO2001027298A2 Sclerotinia-inducible genes and promoters and their uses |
| 04/19/2001 | WO2001027297A2 VERSATILE rpL34 PROMOTER ELEMENTS AND USE THEREOF |
| 04/19/2001 | WO2001027296A1 Regulatory region of a lipid transfer protein (ltpw1) from aleuron tissue of wheat |
| 04/19/2001 | WO2001027295A1 Recombinant attenuated listerias for immunotherapy |
| 04/19/2001 | WO2001027294A1 Virus coat protein/receptor chimeras and methods of use |
| 04/19/2001 | WO2001027293A1 Purification of recombinant proteins fused to multiple epitopes |
| 04/19/2001 | WO2001027292A2 Methods and compositions for targeting a cell |
| 04/19/2001 | WO2001027291A1 Design of a polyepitopic construct for the induction of hla-a2.1 restricted hiv 1 specific ctl responses using hhd mice |
| 04/19/2001 | WO2001027290A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027289A2 Recombinant proteins and peptides for endotoxin biosensors, endotoxin removal, and anti-microbial and anti-endotoxin therapeutics |
| 04/19/2001 | WO2001027288A1 Atr-2 cell cycle checkpoint |
| 04/19/2001 | WO2001027287A2 Telomerase reverse transcriptase (tert) genes |
| 04/19/2001 | WO2001027286A1 Process for producing ubiquinone-10 |
| 04/19/2001 | WO2001027285A1 A novel polypeptide, a human dpb methyltransferase 41 and the polynucleotide encoding the polypeptide |
| 04/19/2001 | WO2001027284A2 Recombinant megalomicin biosynthetic genes and uses thereof |
| 04/19/2001 | WO2001027282A1 Plant virus particles with exogenous internal eitopes |
| 04/19/2001 | WO2001027281A1 Designing immunogens |
| 04/19/2001 | WO2001027280A1 Antimicrobial compositions |
| 04/19/2001 | WO2001027279A1 Human anti-adipocyte monoclonal antibodies and their use |
| 04/19/2001 | WO2001027278A2 A member of the immunoglobulin superfamily and uses thereof |
| 04/19/2001 | WO2001027277A2 Proteins and polynucleotides encoded thereby |
| 04/19/2001 | WO2001027276A2 Dna sequences from breast tumor and uses thereof |
| 04/19/2001 | WO2001027275A1 Novel human membrane proteins |
| 04/19/2001 | WO2001027274A1 Human ldl receptor family proteins and polynucleotides encoding the same |
| 04/19/2001 | WO2001027273A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | WO2001027272A1 Oculomedin and glaucoma |
| 04/19/2001 | WO2001027271A1 Novel c-type lectin and gene thereof |
| 04/19/2001 | WO2001027270A1 Gene ys68 concerning early hematopoiesis |
| 04/19/2001 | WO2001027269A2 Vip54 protein and related materials |
| 04/19/2001 | WO2001027268A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | WO2001027267A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 04/19/2001 | WO2001027266A1 Dna segments that are useful for selecting differentiated cell types and the applications thereof |
| 04/19/2001 | WO2001027265A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/19/2001 | WO2001027264A1 Ribozymes to growth factor originating in human platelet |
| 04/19/2001 | WO2001027263A1 Modulate aptamer and method for detecting target protein by using the same |
| 04/19/2001 | WO2001027262A1 Gene selection using pnas |
| 04/19/2001 | WO2001027261A2 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 04/19/2001 | WO2001027260A1 Template molecule having broad applicability and highly efficient function means of cell-free synthesis of proteins by using the same |
| 04/19/2001 | WO2001027259A1 Method of screening candidate for artificial promoter |
| 04/19/2001 | WO2001027258A2 High yield protein expression system and methods |
| 04/19/2001 | WO2001027256A2 Chimeric transcriptional regulatory element and methods for prostate-targeted gene expression |
| 04/19/2001 | WO2001027255A2 Nucleic acid coding for a ctage gene family, use and production thereof |
| 04/19/2001 | WO2001027254A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | WO2001027252A1 Method to improve the stability and broaden the ph range of family g/11 xylanases |
| 04/19/2001 | WO2001027250A1 Mutase active dna polymerase and use thereof |
| 04/19/2001 | WO2001027248A1 Prpp-amidotransferase from nicotiana tabacum |
| 04/19/2001 | WO2001027246A1 Novel human potassium channel subunit |
| 04/19/2001 | WO2001027241A2 Method of introducing a plurality of genes into plants |
| 04/19/2001 | WO2001027159A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells |
| 04/19/2001 | WO2001027158A2 Olfactory receptor sequences |
| 04/19/2001 | WO2001027157A1 A biologically active complex of nr6 and cardiotrophin-like-cytokine |
| 04/19/2001 | WO2001027156A1 Interleukin-2 like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027154A2 Membrane translocating peptide drug delivery system |
| 04/19/2001 | WO2001027153A1 A murine seven-transmembrane receptor, mus musculus mhneaa81 |
| 04/19/2001 | WO2001027152A1 Method of altering polypeptide aggregation |
| 04/19/2001 | WO2001027151A1 A new polypeptide-human zinc finger protein kruppel family member zfp-52 and the polynucleotide encoding it |
| 04/19/2001 | WO2001027150A2 Anthozoa derived chromo/fluoroproteins and methods for using the same |
| 04/19/2001 | WO2001027149A1 Human cervical cancer 1 protooncogene and protein encoded therein |
| 04/19/2001 | WO2001027148A1 A novel polypeptide-homo glutamine(q)-rich factor 56 and polynucleotide encoding said polypeptide |
| 04/19/2001 | WO2001027146A2 Chemokine receptor |
| 04/19/2001 | WO2001027144A2 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 04/19/2001 | WO2001027143A1 Lantibiotic |
| 04/19/2001 | WO2001026678A1 Short segments of dap-kinase |
| 04/19/2001 | WO2001026676A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | WO2001026643A1 Inhibition of tumorigenic properties of melanoma cells |
| 04/19/2001 | WO2001026608A2 Dna vaccines encoding antigen linked to a domain that binds cd40 |
| 04/19/2001 | WO2001026459A2 Flowering time modification |
| 04/19/2001 | WO2001026458A2 Process for increasing crop yield or biomass using protoporphyrinogen oxidase gene |
| 04/19/2001 | WO2001026455A1 Methods of producing a target molecule in a transgenic animal and purification of the target molecule |
| 04/19/2001 | WO2001026454A1 Preparation and selection of donor cells for nuclear transplantation |
| 04/19/2001 | WO2001026453A1 Atp-binding cassette transporter (abc1) modified transgenic mice |
| 04/19/2001 | WO2001026450A1 Method for increasing transgenic biomass |